Zobrazeno 1 - 10 of 188 pro vyhledávání: '"Sanchez-Felix M"'
1
Akademický článek
Pharmaceutical and biotech industry perspectives on optimizing patient experience and treatment adherence through subcutaneous drug delivery design.
Autor: Stevenson J; Amgen, One Amgen Center Drive, Thousand Oaks, CA 91320, USA. Electronic address: jlsteven@amgen.com., Poker R; AstraZeneca, Human Factors Engineering, BioPharmaceutical Development, Biopharmaceuticals R&D, 121 Oyster Point Blvd, South San Francisco, CA 94080, USA., Schoss J; Biogen, 225 Binney St, Cambridge, MA 02142, USA., Campbell M; Janssen, 200 Great Valley Pkwy, Malvern, PA 19355, USA., Everitt C; Pfizer, Granta Park, Great Abington, Cambridge CB21 6GP, UK., Holly B; Pfizer, Granta Park, Great Abington, Cambridge CB21 6GP, UK., Stones N; Novartis Pharma AG, Lichtstrasse 35, CH-4056 Basel, Switzerland., Pettis RJ; Becton-Dickinson, 21 Davis Drive, Research Triangle Park, NC 27513, USA., Sanchez-Felix M; Halozyme Therapeutics, Inc., 12390 El Camino Real, San Diego, CA 92130, USA.
Publikováno v: Advanced drug delivery reviews [Adv Drug Deliv Rev] 2024 Jun; Vol. 209, pp. 115322. Date of Electronic Publication: 2024 Apr 26.
Zobrazit plný text záznamu
2
Akademický článek
Protein Based Amorphous Solid Dispersion: a Case Study Investigating Different Whey Proteins at High Drug Loading.
Autor: Leng D; Zerion Pharma A/S, Fruebjergvej 3, 2100, Copenhagen, Denmark., Bulduk B; Zerion Pharma A/S, Fruebjergvej 3, 2100, Copenhagen, Denmark., Widmer T; Science for Novartis Pharma AG, Lichtstrasse 35, Ch-4002, Basel, Switzerland., Wiborg O; Zerion Pharma A/S, Fruebjergvej 3, 2100, Copenhagen, Denmark., Sanchez-Felix M; Science for Novartis Pharma AG, Lichtstrasse 35, Ch-4002, Basel, Switzerland., Löbmann K; Zerion Pharma A/S, Fruebjergvej 3, 2100, Copenhagen, Denmark. kl@zerion.eu.
Publikováno v: Pharmaceutical research [Pharm Res] 2023 Jul; Vol. 40 (7), pp. 1865-1872. Date of Electronic Publication: 2023 May 26.
Zobrazit plný text záznamu
3
Akademický článek
Smart design of patient-centric long-acting products: from preclinical to marketed pipeline trends and opportunities.
Autor: Bassand C; Technical Research and Development, Novartis Pharma AG, Basel, Switzerland., Villois A; Technical Research and Development, Novartis Pharma AG, Basel, Switzerland., Gianola L; Novartis Institute for Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Laue G; Novartis Institute for Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Ramazani F; Technical Research and Development, Novartis Pharma AG, Basel, Switzerland., Riebesehl B; Technical Research and Development, Novartis Pharma AG, Basel, Switzerland., Sanchez-Felix M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA., Sedo K; PharmaCircle LLC, Sunny Isles Beach, FL, USA., Ullrich T; Novartis Institute for Biomedical Research, Novartis Pharma AG, Basel, Switzerland., Duvnjak Romic M; Technical Research and Development, Novartis Pharma AG, Basel, Switzerland.
Publikováno v: Expert opinion on drug delivery [Expert Opin Drug Deliv] 2022 Oct; Vol. 19 (10), pp. 1265-1283. Date of Electronic Publication: 2022 Aug 02.
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Inhibition of S. aureus Infection of Human Umbilical Vein Endothelial Cells (HUVECs) by Trehalose- and Glucose-Functionalized Gold Nanoparticles.
Autor: Li Y; Centre for Advanced Macromolecular Design, School of Chemistry, University of New South Wales, Sydney, NSW, 2052, Australia., Ariotti N; Electron Microscope Unit, Mark Wainwright Analytical Centre, University of New South Wales, Sydney, NSW, 2052, Australia., Aghaei B; Inventia Life Science Pty Ltd, Sydney, NSW, 2015, Australia.; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW, 2052, Australia., Pandzic E; Katharina Gaus Light Microscopy Facility, Mark Wainwright Analytical Centre, University of New South Wales, Sydney, NSW, 2052, Australia., Ganda S; Centre for Advanced Macromolecular Design, School of Chemistry, University of New South Wales, Sydney, NSW, 2052, Australia., Willcox M; School of Optometry and Vision Science, University of New South Wales, Sydney, NSW, 2052, Australia., Sanchez-Felix M; Novartis Institutes for BioMedical Research, Cambridge, MA, 02139, USA., Stenzel M; Centre for Advanced Macromolecular Design, School of Chemistry, University of New South Wales, Sydney, NSW, 2052, Australia.
Publikováno v: Angewandte Chemie (International ed. in English) [Angew Chem Int Ed Engl] 2021 Oct 11; Vol. 60 (42), pp. 22652-22658. Date of Electronic Publication: 2021 Sep 09.
Zobrazit plný text záznamu
6
Akademický článek
The Evolving Druggability and Developability Space: Chemically Modified New Modalities and Emerging Small Molecules.
Autor: Yang W; Early Product Development, Pharmaceutical Sciences, R&D, AstraZeneca, Boston, Massachusetts, 02451, USA. wenzhan.yang@astrazeneca.com., Gadgil P; Analytical Development-Pharmaceutics Research, Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, 02139, USA., Krishnamurthy VR; Advance Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Boston, Massachusetts, 02451, USA., Landis M; Molecular Pharmaceutics, Pharmaceutical Sciences, Pfizer Global Research and Development, Cambridge, Massachusetts, 02139, USA., Mallick P; Pharmacology, Metabolism & Pharmacokinetics Division, ScitoVation, Durham, North Carolina, 27713, USA., Patel D; Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Inc., Princeton, New Jersey, 08543, USA., Patel PJ; Small Molecule Design and Development, Eli Lilly and Company, Indianapolis, Indiana, 46285, USA., Reid DL; Synthetics Enabling Technologies, Pre-Pivotal Drug Product, Drug Product Technologies, Amgen, Inc., Cambridge, Massachusetts, 02142, USA., Sanchez-Felix M; Chemical & Pharmaceutical Profiling (CPP), Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, 02139, USA.
Publikováno v: The AAPS journal [AAPS J] 2020 Jan 03; Vol. 22 (2), pp. 21. Date of Electronic Publication: 2020 Jan 03.
Zobrazit plný text záznamu
7
Akademický článek
Measurable therapeutic antibody in serum as potential predictive factor of response to anti-CD38 therapy in non-IgG-k myeloma patients.
Autor: Gigliotta, Emilia1 (AUTHOR), Plano, Federica1 (AUTHOR), Corsale, Giusy1 (AUTHOR), Corsale, Anna Maria1 (AUTHOR), Aquilina, Cristina1 (AUTHOR), Speciale, Maria1 (AUTHOR), Rizzuto, Andrea1 (AUTHOR), Martino, Enrica Antonia2 (AUTHOR), Leotta, Dario2 (AUTHOR), Solimando, Antonio Giovanni3 (AUTHOR), Ria, Roberto3 (AUTHOR), Gentile, Massimo2,4 (AUTHOR), Siragusa, Sergio1 (AUTHOR), Botta, Cirino1 (AUTHOR) Cirino.botta@unipa.it
Publikováno v: Experimental Hematology & Oncology. 8/6/2024, Vol. 13 Issue 1, p1-5. 5p.
Zobrazit plný text záznamu
8
Akademický článek
Population pharmacokinetic modeling of sotatercept in healthy participants and patients with pulmonary arterial hypertension.
Autor: Ait‐Oudhia, Sihem1 (AUTHOR) sihem.bihorel@merck.com, Jaworowicz, David2 (AUTHOR), Hu, Ziheng1 (AUTHOR), Bihorel, Sébastien2 (AUTHOR), Hu, Shuai1 (AUTHOR), Balasubrahmanyam, Budda3 (AUTHOR), Mistry, Bipin3 (AUTHOR), de Oliveira Pena, Janethe1 (AUTHOR), Wenning, Larissa1 (AUTHOR), Gheyas, Ferdous1 (AUTHOR)
Publikováno v: CPT: Pharmacometrics & Systems Pharmacology. Aug2024, Vol. 13 Issue 8, p1380-1393. 14p.
Zobrazit plný text záznamu
9
Akademický článek
Use of Poly(vinyl alcohol) in Spray-Dried Dispersions: Enhancing Solubility and Stability of Proteolysis Targeting Chimeras.
Autor: Mareczek, Lena1 (AUTHOR), Mueller, Lena K.1 (AUTHOR) lena.mueller@merckgroup.com, Halstenberg, Laura1 (AUTHOR), Geiger, Thomas M.2 (AUTHOR), Walz, Michael2 (AUTHOR), Zheng, Min2 (AUTHOR), Hausch, Felix2,3 (AUTHOR)
Publikováno v: Pharmaceutics. Jul2024, Vol. 16 Issue 7, p924. 13p.
Zobrazit plný text záznamu
10
Akademický článek
Prediction of ARA/PPI Drug-Drug Interactions at the Drug Discovery and Development Interface.
Autor: Dodd S; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139. Electronic address: stephanie.dodd@novartis.com., Kollipara S; Novartis Healthcare Pvt Ltd., Hyderabad 500078, India., Sanchez-Felix M; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139., Kim H; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts 02139., Meng Q; China Novartis Institutes for Biomedical Research Co. Ltd, Shanghai 201203, China., Beato S; Novartis Pharma AG, CH 4056, Basel, Switzerland., Heimbach T; Novartis Institutes for BioMedical Research, East Hanover, New Jersey 07936.
Publikováno v: Journal of pharmaceutical sciences [J Pharm Sci] 2019 Jan; Vol. 108 (1), pp. 87-101. Date of Electronic Publication: 2018 Oct 29.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje